Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
06 Jun 2017 NICE Issues Quality Standard for Haematological Cancers Haematologic malignancies
02 Jun 2017 A Need to Harmonise the Prescribing Information for Etoposide in the EU Anticancer agents & Biologic therapy
01 Jun 2017 FDA Accepts for Priority Review Application for Nivolumab in Previously Treated Hepatocellular Carcinoma Gastrointestinal cancers - Cancer Immunology and Immunotherapy
31 May 2017 FDA Broadens Ceritinib Indication to Previously Untreated ALK-positive Metastatic NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 May 2017 NICE Terminates Technology Appraisal for Afatinib in Advanced Squamous NSCLC After Platinum-based Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 May 2017 FDA Grants Accelerated Approval to Pembrolizumab for Unresectable or Metastatic MSI-H or dMMR Solid Tumours Cancer Immunology and Immunotherapy
26 May 2017 Withdrawal of the Marketing Authorisation Application for Vosaroxin Haematologic malignancies - Anticancer agents & Biologic therapy
24 May 2017 EMA Completes an Arbitration Procedure for Dexrazoxane Palliative and supportive care
22 May 2017 EMA Adopts a Negative Opinion for Anamorelin Hydrochloride Palliative and supportive care - Lung and other thoracic tumours
22 May 2017 EMA Adopts a New Indication for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 May 2017 FDA Grants Approval to Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
18 May 2017 EMA Launches Public Consultations to Revise Three Scientific Guidelines Bioethics, legal and economic issues
17 May 2017 NaviCam for Diagnosing Gastrointestinal Tract Conditions Diagnosis, Imaging and Staging
16 May 2017 Severe Skin Reactions from Pembrolizumab Palliative and supportive care - Cancer Immunology and Immunotherapy
15 May 2017 FDA Approves Ribociclib-Letrozole Co-Pack for Initial Treatment of HR-positive/HER2-negative Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy